UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 281

Sortiert nach

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A

The New England journal of medicine, 2023-02, Vol.388 (8), p.694-705

2023

Volltextzugriff (PDF)

An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo

Nano letters, 2015-12, Vol.15 (12), p.8099-8107

2015

Volltextzugriff (PDF)

Andexanet Alfa Versus Prothrombin Complex Concentrates/Blood Products as Apixaban/Rivaroxaban Reversal Agents: A Survey Among Pediatric Hematologists

Clinical and applied thrombosis/hemostasis, 2022-03, Vol.28, p.10760296221078842-10760296221078842

2022

Volltextzugriff (PDF)

Pediatric Bleeding Disorders: A Clinical Casebook

1st ed. 2020., 2020

Volltextzugriff (PDF)

Efficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia A and B with inhibitors

Expert review of hematology, 2023-10, Vol.16 (10), p.715-729

2023

Volltextzugriff (PDF)

Increasing optimal coagulation factor dosing in the paediatric emergency department: Update to a quality improvement study

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-03, Vol.30 (2), p.367-374

2024

Volltextzugriff (PDF)

Can virtual reality change the paediatric health-care experience?

The Lancet. Haematology, 2020-03, Vol.7 (3), p.e195-e195

Dunn, Amy L

2020

Volltextzugriff (PDF)

Mild Hemophilia In A Competitive High School Soccer Player: A Case Report

Journal of athletic training, 2023-07, Vol.58 (7-8), p.669-672

2023

Volltextzugriff (PDF)

Venous Thromboembolism in Children with Sickle Cell Disease: A Retrospective Cohort Study

The Journal of pediatrics, 2018-06, Vol.197, p.186-190.e1

2018

Volltextzugriff (PDF)

Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment

British journal of haematology, 2017-10, Vol.179 (2), p.298-307

2017

Volltextzugriff (PDF)

Moderate-intensity aerobic exercise vs desmopressin in adolescent males with mild hemophilia A: a randomized trial

Blood, 2022-09, Vol.140 (10), p.1156-1166

2022

Volltextzugriff (PDF)

Anti-Factor Xa–Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort

The Journal of pediatrics, 2019-06, Vol.209, p.212-219.e1

2019

Volltextzugriff (PDF)

International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-05, Vol.30 (3), p.862-864

2024

Volltextzugriff (PDF)

Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A

Journal of thrombosis and haemostasis, 2024-07, Vol.22 (7), p.1880-1893

2024

Volltextzugriff (PDF)

Screening urinalysis demonstrates that haematuria is a frequent finding in persons with haemophilia treated at a paediatric haemophilia treatment centre

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-09, Vol.25 (5), p.782-788

2019

Volltextzugriff (PDF)

A regional anticoagulation program improves safety and outcomes for both children and adults

Journal of thrombosis and thrombolysis, 2023-07, Vol.56 (1), p.27-36

2023

Volltextzugriff (PDF)

Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1

Journal of thrombosis and haemostasis, 2023-12, Vol.21 (12), p.3450-3462

2023

Volltextzugriff (PDF)

Optimizing patient flow in a multidisciplinary haemophilia clinic using quality improvement methodology

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-07, Vol.25 (4), p.626-632

2019

Volltextzugriff (PDF)

Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male

Pediatric blood & cancer, 2019-09, Vol.66 (9), p.e27832-n/a

2019

Volltextzugriff (PDF)

Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years

The Lancet. Haematology, 2022-09, Vol.9 (9), p.e689-e697

2022

Volltextzugriff (PDF)

Adherence of Mobile App-Based Surveys and Comparison With Traditional Surveys: eCohort Study

Journal of medical Internet research, 2021-01, Vol.23 (1), p.e24773-e24773

2021

Volltextzugriff (PDF)

Increasing optimal coagulation factor dosing in the paediatric emergency department: A quality improvement study

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-03, Vol.25 (2), p.258-263

2019

Volltextzugriff (PDF)

Factor IX inhibitors: Clinical and laboratory profiles of two patients with severe haemophilia B

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-03, Vol.25 (2), p.e126-e129

2019

Volltextzugriff (PDF)

Radionuclide synovectomy for hemophilic arthropathy: a comprehensive review of safety and efficacy and recommendation for a standardized treatment protocol

Thrombosis and haemostasis, 2002-03, Vol.87 (3), p.383

2002

Volltextzugriff (PDF)

Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-07, Vol.28 (4), p.548-556

2022

Volltextzugriff (PDF)

1 – 25 von 281

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(226)
Mit Volltextzugriff
(238)

Publikationsform

Artikel
(235)
Buchkapitel
(41)
Bücher
(4)
Berichte
(1)

Sprache

Englisch
(280)
Japanisch
(24)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A

An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo

Andexanet Alfa Versus Prothrombin Complex Concentrates/Blood Products as Apixaban/Rivaroxaban Reversal Agents: A Survey Among Pediatric Hematologists

Pediatric Bleeding Disorders: A Clinical Casebook

Efficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia A and B with inhibitors

Increasing optimal coagulation factor dosing in the paediatric emergency department: Update to a quality improvement study

Can virtual reality change the paediatric health-care experience?

Mild Hemophilia In A Competitive High School Soccer Player: A Case Report

Venous Thromboembolism in Children with Sickle Cell Disease: A Retrospective Cohort Study

Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment

Moderate-intensity aerobic exercise vs desmopressin in adolescent males with mild hemophilia A: a randomized trial

Anti-Factor Xa–Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort

International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0

Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A

Screening urinalysis demonstrates that haematuria is a frequent finding in persons with haemophilia treated at a paediatric haemophilia treatment centre

A regional anticoagulation program improves safety and outcomes for both children and adults

Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1

Optimizing patient flow in a multidisciplinary haemophilia clinic using quality improvement methodology

Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male

Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years

Adherence of Mobile App-Based Surveys and Comparison With Traditional Surveys: eCohort Study

Increasing optimal coagulation factor dosing in the paediatric emergency department: A quality improvement study

Factor IX inhibitors: Clinical and laboratory profiles of two patients with severe haemophilia B

Radionuclide synovectomy for hemophilic arthropathy: a comprehensive review of safety and efficacy and recommendation for a standardized treatment protocol

Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors

Suchergebnisse filtern